0 XP   0   0   0

Lipum AB
Buy, Hold or Sell?

I guess you are interested in Lipum AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Lipum

Let's start. I'm going to help you getting a better view of Lipum AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Lipum AB even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Lipum AB is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Lipum AB. The closing price on 2022-09-30 was kr15.35 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Lipum AB Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Lipum AB.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Lipum earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lipum AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1,252,007.9%-1,252,007.9%
TTM-5Y626,004.0%-626,004.0%
5Y626,004.0%10Y626,004.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--242.4%+242.4%
TTM--275.9%+275.9%
YOY1,252,007.9%-342.1%+1,252,350.0%
5Y626,004.0%-475.7%+626,479.7%
10Y626,004.0%-561.7%+626,565.7%
1.1.2. Return on Assets

Shows how efficient Lipum is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • -31.8% Return on Assets means that Lipum generated kr-0.32 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lipum AB:

  • The MRQ is -40.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -31.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-40.8%TTM-31.8%-8.9%
TTM-31.8%YOY-43.3%+11.5%
TTM-31.8%5Y-37.6%+5.8%
5Y-37.6%10Y-37.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-40.8%-9.7%-31.1%
TTM-31.8%-8.7%-23.1%
YOY-43.3%-9.2%-34.1%
5Y-37.6%-11.5%-26.1%
10Y-37.6%-12.4%-25.2%
1.1.3. Return on Equity

Shows how efficient Lipum is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • -72.5% Return on Equity means the company generated kr-0.73 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lipum AB:

  • The MRQ is -72.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -53.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-72.5%TTM-53.3%-19.2%
TTM-53.3%YOY-127.5%+74.1%
TTM-53.3%5Y-90.4%+37.1%
5Y-90.4%10Y-90.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-72.5%-11.8%-60.7%
TTM-53.3%-11.1%-42.2%
YOY-127.5%-10.6%-116.9%
5Y-90.4%-13.5%-76.9%
10Y-90.4%-14.5%-75.9%

1.2. Operating Efficiency of Lipum AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lipum is operating .

  • Measures how much profit Lipum makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lipum to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lipum AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1,148,624.3%-1,148,624.3%
TTM-5Y574,312.2%-574,312.2%
5Y574,312.2%10Y574,312.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.1%+232.1%
TTM--269.6%+269.6%
YOY1,148,624.3%-309.3%+1,148,933.6%
5Y574,312.2%-466.7%+574,778.9%
10Y574,312.2%-572.5%+574,884.7%
1.2.2. Operating Ratio

Measures how efficient Lipum is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are kr0.00for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Lipum AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-12,469.135+12,469.135
TTM-5Y-6,234.568+6,234.568
5Y-6,234.56810Y-6,234.5680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.321-3.321
TTM-3.542-3.542
YOY-12,469.1353.491-12,472.626
5Y-6,234.5685.744-6,240.312
10Y-6,234.5687.007-6,241.575

1.3. Liquidity of Lipum AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lipum is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 316.3% means the company has kr3.16 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Lipum AB:

  • The MRQ is 3.163. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.709. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.163TTM6.709-3.546
TTM6.709YOY3.307+3.402
TTM6.7095Y5.008+1.701
5Y5.00810Y5.0080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1635.266-2.103
TTM6.7096.060+0.649
YOY3.3076.366-3.059
5Y5.0086.692-1.684
10Y5.0086.457-1.449
1.3.2. Quick Ratio

Measures if Lipum is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 303.1% means the company can pay off kr3.03 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lipum AB:

  • The MRQ is 3.031. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.672. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.031TTM6.672-3.641
TTM6.672YOY3.224+3.448
TTM6.6725Y4.948+1.724
5Y4.94810Y4.9480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0314.055-1.024
TTM6.6724.865+1.807
YOY3.2245.192-1.968
5Y4.9485.275-0.327
10Y4.9484.997-0.049

1.4. Solvency of Lipum AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lipum assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.44 means that Lipum assets are financed with 43.8% credit (debt) and the remaining percentage (100% - 43.8%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Lipum AB:

  • The MRQ is 0.438. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.312. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.438TTM0.312+0.126
TTM0.312YOY0.367-0.055
TTM0.3125Y0.340-0.028
5Y0.34010Y0.3400.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4380.271+0.167
TTM0.3120.269+0.043
YOY0.3670.296+0.071
5Y0.3400.361-0.021
10Y0.3400.399-0.059
1.4.2. Debt to Equity Ratio

Measures if Lipum is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 77.9% means that company has kr0.78 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lipum AB:

  • The MRQ is 0.779. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.514. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.779TTM0.514+0.266
TTM0.514YOY1.094-0.580
TTM0.5145Y0.804-0.290
5Y0.80410Y0.8040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7790.310+0.469
TTM0.5140.311+0.203
YOY1.0940.310+0.784
5Y0.8040.382+0.422
10Y0.8040.438+0.366

2. Market Valuation of Lipum AB

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Lipum.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -3.14 means the investor is paying kr-3.14 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lipum AB:

  • The EOD is -3.713. Company is losing money. -2
  • The MRQ is -3.145. Company is losing money. -2
  • The TTM is -5.182. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-3.713MRQ-3.145-0.568
MRQ-3.145TTM-5.182+2.037
TTM-5.182YOY-1.736-3.446
TTM-5.1825Y-3.459-1.723
5Y-3.45910Y-3.4590.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.713-2.115-1.598
MRQ-3.145-2.332-0.813
TTM-5.182-3.889-1.293
YOY-1.736-5.087+3.351
5Y-3.459-3.697+0.238
10Y-3.459-3.390-0.069
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Lipum.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Lipum AB:

  • The MRQ is -0.077. Very Bad. -2
  • The TTM is -0.077. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.077TTM-0.0770.000
TTM-0.0775Y-0.0770.000
5Y-0.07710Y-0.0770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0770.003-0.080
TTM-0.0770.019-0.096
5Y-0.0770.020-0.097
10Y-0.0770.017-0.094

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Lipum is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.65 means the investor is paying kr6.65 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Lipum AB:

  • The EOD is 7.853. Seems overpriced? -1
  • The MRQ is 6.651. Seems overpriced? -1
  • The TTM is 10.225. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD7.853MRQ6.651+1.202
MRQ6.651TTM10.225-3.574
TTM10.225YOY0.408+9.817
TTM10.2255Y5.317+4.908
5Y5.31710Y5.3170.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD7.8531.843+6.010
MRQ6.6511.961+4.690
TTM10.2252.789+7.436
YOY0.4083.538-3.130
5Y5.3172.782+2.535
10Y5.3172.419+2.898

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lipum AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--1.9554.325-55%3.441-43%3.883-50%3.883-50%
Book Value Per Share Growth---1.411-2.633+87%3.121-145%0.244-678%0.244-678%
Current Ratio--3.1636.709-53%3.307-4%5.008-37%5.008-37%
Debt To Asset Ratio--0.4380.312+40%0.367+19%0.340+29%0.340+29%
Debt To Equity Ratio--0.7790.514+52%1.094-29%0.804-3%0.804-3%
Dividend Per Share----0%-0%-0%-0%
Eps---1.417-1.033-27%-0.735-48%-0.884-38%-0.884-38%
Eps Growth--40.67340.6730%--40.6730%40.6730%
Gains Per Share---1.411-2.633+87%3.121-145%0.244-678%0.244-678%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%12520.079-100%6260.040-100%6260.040-100%
Operating Margin----0%11486.243-100%5743.122-100%5743.122-100%
Operating Ratio----0%-12469.1350%-6234.5680%-6234.5680%
Pb Ratio7.853+15%6.65110.225-35%0.408+1528%5.317+25%5.317+25%
Pe Ratio-3.713-18%-3.145-5.182+65%-1.736-45%-3.459+10%-3.459+10%
Peg Ratio---0.077-0.0770%---0.0770%-0.0770%
Price Per Share15.350+15%13.00017.445-25%5.100+155%11.273+15%11.273+15%
Quick Ratio--3.0316.672-55%3.224-6%4.948-39%4.948-39%
Return On Assets---0.408-0.318-22%-0.433+6%-0.376-8%-0.376-8%
Return On Equity---0.725-0.533-26%-1.275+76%-0.904+25%-0.904+25%
 EOD+1 -2MRQTTM+4 -9YOY+4 -115Y+2 -1310Y+2 -13

3.2. Fundamental Score

Let's check the fundamental score of Lipum AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.713
Price to Book Ratio (EOD)Between0-17.853
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.031
Current Ratio (MRQ)Greater than13.163
Debt to Asset Ratio (MRQ)Less than10.438
Debt to Equity Ratio (MRQ)Less than10.779
Return on Equity (MRQ)Greater than0.15-0.725
Return on Assets (MRQ)Greater than0.05-0.408
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Lipum AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.473
Ma 20Greater thanMa 5015.083
Ma 50Greater thanMa 10015.784
Ma 100Greater thanMa 20014.974
OpenGreater thanClose15.000
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets22,906
Total Liabilities10,031
Total Stockholder Equity12,875
 As reported
Total Liabilities 10,031
Total Stockholder Equity+ 12,875
Total Assets = 22,906

Assets

Total Assets22,906
Total Current Assets21,038
Long-term Assets21,038
Total Current Assets
Cash And Cash Equivalents 18,783
Net Receivables 1,378
Total Current Assets  (as reported)21,038
Total Current Assets  (calculated)20,161
+/- 877
Long-term Assets
Property Plant Equipment 55
Other Assets 1,813
Long-term Assets  (as reported)1,868
Long-term Assets  (calculated)1,868
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,652
Long-term Liabilities3,379
Total Stockholder Equity12,875
Total Current Liabilities
Accounts payable 3,481
Other Current Liabilities 3,171
Total Current Liabilities  (as reported)6,652
Total Current Liabilities  (calculated)6,652
+/-0
Long-term Liabilities
Long term Debt 1,566
Other Liabilities 1,813
Long-term Liabilities  (as reported)3,379
Long-term Liabilities  (calculated)3,379
+/-0
Total Stockholder Equity
Common Stock1,263
Retained Earnings -103,434
Other Stockholders Equity 115,046
Total Stockholder Equity (as reported)12,875
Total Stockholder Equity (calculated)12,875
+/-0
Other
Capital Stock1,263
Cash and Short Term Investments 18,783
Common Stock Shares Outstanding 6,587
Liabilities and Stockholders Equity 22,906
Net Debt -17,217
Net Invested Capital 14,441
Net Tangible Assets 12,875
Net Working Capital 14,386
Short Long Term Debt Total 1,566



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
10,088
0
70,795
62,471
49,662
31,015
22,906
22,90631,01549,66262,47170,795010,0880
   > Total Current Assets 
0
10,088
0
70,795
62,471
48,102
29,268
21,038
21,03829,26848,10262,47170,795010,0880
       Cash And Cash Equivalents 
0
4,440
0
68,730
61,941
47,053
27,971
18,783
18,78327,97147,05361,94168,73004,4400
       Net Receivables 
0
5,648
0
0
530
1,049
1,205
1,378
1,3781,2051,049530005,6480
       Other Current Assets 
0
5,648
0
2,065
530
1,049
1,297
2,255
2,2551,2971,0495302,06505,6480
   > Long-term Assets 
0
0
0
0
0
1,560
1,747
1,868
1,8681,7471,56000000
       Property Plant Equipment 
0
0
0
0
0
0
60
55
5560000000
       Other Assets 
0
1,054
0
0
0
1,560
1,687
1,813
1,8131,6871,5600001,0540
> Total Liabilities 
0
6,861
0
7,712
5,415
21,781
8,845
10,031
10,0318,84521,7815,4157,71206,8610
   > Total Current Liabilities 
0
5,385
0
6,236
3,939
18,655
5,592
6,652
6,6525,59218,6553,9396,23605,3850
       Accounts payable 
0
653
0
1,264
865
1,375
2,196
3,481
3,4812,1961,3758651,26406530
       Other Current Liabilities 
0
4,732
0
4,972
3,074
17,280
3,396
3,171
3,1713,39617,2803,0744,97204,7320
   > Long-term Liabilities 
0
1,476
0
1,476
1,476
3,126
3,253
3,379
3,3793,2533,1261,4761,47601,4760
       Other Liabilities 
0
1,054
0
0
0
1,560
1,687
1,813
1,8131,6871,5600001,0540
> Total Stockholder Equity
0
3,227
0
63,083
57,056
27,881
22,170
12,875
12,87522,17027,88157,05663,08303,2270
   Common Stock
0
236
0
1,263
1,263
1,263
1,263
1,263
1,2631,2631,2631,2631,26302360
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
0
38,810
0
115,450
115,046
115,046
115,046
115,046
115,046115,046115,046115,046115,450038,8100



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-53,476
Operating Income-52,106-53,476
 
Operating Expense (+$)
Research Development-
Selling General Administrative48,693
Selling And Marketing Expenses-
Operating Expense53,47648,693
 
Net Interest Income (+$)
Interest Income0
Interest Expense-150
Net Interest Income-150-150
 
Pretax Income (+$)
Operating Income-52,106
Net Interest Income-150
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-52,256-51,956
EBIT - interestExpense = -53,626
-52,256
-52,106
Interest Expense150
Earnings Before Interest and Taxes (ebit)-53,476-52,106
Earnings Before Interest and Taxes (ebitda)-52,106
 
After tax Income (+$)
Income Before Tax-52,256
Tax Provision--
Net Income From Continuing Ops-52,256-52,256
Net Income-52,256
Net Income Applicable To Common Shares-52,256
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses53,476
Total Other Income/Expenses Net-150150
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
6 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
6 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
6 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
6 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
6 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
6 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
6 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
6 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart